This therapy is one of a few drugs in mid-to-late-stage development for Parkinson’s that has displayed disease-modifying ...

Hope is preparing for close-out meetings with the FDA. Chang said the team is “hopeful to advance to a phase 3 confirmatory trial” of the stem cell therapy candidate.

With around one million people living with Parkinson’s disease in the U.S. — and 90,000 getting new diagnoses each year — the race is on for a cure. Researchers at Memorial Sloan Kettering Cancer ...

Parkinson's disease (PD) is an age-related, progressive, neurodegenerative condition, caused by loss of dopamine-producing neurons.

Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF) today shares positive top-line results of a Phase II clinical trial to evaluate Hope Biosciences' allogeneic ...

Chinese scientists have developed a groundbreaking stem cell therapy for Parkinson's disease. Their treatment serves an ...

MSK physician-scientists Dr. Viviane Tabar and Dr. Lorenz Studer have developed a treatment for Parkinson’s disease that involves creating nerve cells from embryonic stem cells and transplanting them ...

A cell culture plate with pluripotent stem cells, which can differentiate into any kind of cell in the body. National Center for Advancing Translational Sciences A treatment that could replenish cells ...

Patients suffering from Parkinson's disease may soon benefit from a powerful treatment option: stem-cell transplants. In a pair of small studies designed primarily to test safety, two teams of ...

Two small clinical trials revive hope for an old idea: Cells injected into the brain might replace the nerve cells that die in Parkinson’s disease. The studies, published April 16 in Nature, represent ...